C8-ceramide modulates microglia BDNF expression to alleviate postoperative cognition dysfunction via PKCδ/NF-κB signaling pathway

Guangqian Li,Yuhao Wang,Lei Qian,Danni Li,Yuchen Yao,Jian Pan,Dan Fan
DOI: https://doi.org/10.1007/s00221-024-06847-2
2024-05-17
Experimental Brain Research
Abstract:Postoperative cognitive dysfunction (POCD) is a kind of serious postoperative complication in surgery with general anesthesia and it may affect patients' normal lives. Activated microglia are thought to be one of the key factors in the regulation of POCD process. Once activated, resident microglia change their phenotype and secrete kinds of cytokines to regulate inflammatory response in tissues. Among these secretory factors, brain-derived neurotrophic factor (BDNF) is considered to be able to inhibit inflammation response and protect nervous system. Therefore, the enhancement of BDNF expression derived from resident microglia is suggested to be potential treatment for POCD. In our study, we focused on the role of C8-ceramide (a kind of interventional drug) and assessed its regulatory effect on improving the expression of BDNF secreted from microglia to treat POCD. According to the results of our study, we observed that C8-ceramide stimulated primary microglia to up-regulate the expression of BDNF mRNA after being treated with lipopolysaccharide (LPS) in vitro. We proved that C8-ceramide had ability to effectively improve POCD of mice after being accepted carotid artery exposure and their abnormal behavior recovered better than that of mice from the surgery group. Furthermore, we also demonstrated that C8-ceramide enhanced the cognitive function of mice via the PKCδ/NF-κB signaling pathway. In general, our study has confirmed a potential molecular mechanism that led to the occurrence of POCD caused by surgery and provided a new clinical strategy to treat POCD.
neurosciences
What problem does this paper attempt to address?
The problem that this paper attempts to solve is the treatment of postoperative cognitive dysfunction (POCD). POCD is a serious complication that may occur after general anesthesia surgery and may affect the patient's quality of life. Studies have pointed out that activated microglia are considered to be one of the key factors in regulating the process of POCD. Once activated, resident microglia will change their phenotype and secrete a variety of cytokines to regulate the inflammatory response in tissues. Among them, brain - derived neurotrophic factor (BDNF) is considered to be able to inhibit the inflammatory response and protect the nervous system. Therefore, enhancing the BDNF expression from resident microglia is considered a potential method for treating POCD. Specifically, this study focused on the role of C8 - ceramide (an intervention drug) and evaluated its regulatory effect on treating POCD by improving the BDNF expression secreted by microglia. The research results show that C8 - ceramide can stimulate primary microglia to up - regulate the expression of BDNF mRNA after being treated with lipopolysaccharide (LPS) in vitro. In addition, the study also proved that C8 - ceramide can effectively improve the POCD of mice undergoing carotid artery exposure surgery, making their abnormal behaviors recover better than those of the mice in the surgery group. Further research shows that C8 - ceramide enhances the cognitive function of mice through the PKCδ/NF - κB signaling pathway. Overall, this study identified a potential molecular mechanism that may lead to POCD caused by surgery and provided a new clinical strategy for treating POCD.